作者
Suzanne V Arnold, Deepak L Bhatt, Gregory W Barsness, Alexis L Beatty, Prakash C Deedwania, Silvio E Inzucchi, Mikhail Kosiborod, Lawrence A Leiter, Kasia J Lipska, Jonathan D Newman, Francine K Welty, American Heart Association Council on Lifestyle and Cardiometabolic Health and Council on Clinical Cardiology
发表日期
2020/5/12
来源
Circulation
卷号
141
期号
19
页码范围
e779-e806
出版商
Lippincott Williams & Wilkins
简介
Although cardiologists have long treated patients with coronary artery disease (CAD) and concomitant type 2 diabetes mellitus (T2DM), T2DM has traditionally been considered just a comorbidity that affected the development and progression of the disease. Over the past decade, a number of factors have shifted that have forced the cardiology community to reconsider the role of T2DM in CAD. First, in addition to being associated with increased cardiovascular risk, T2DM has the potential to affect a number of treatment choices for CAD. In this document, we discuss the role that T2DM has in the selection of testing for CAD, in medical management (both secondary prevention strategies and treatment of stable angina), and in the selection of revascularization strategy. Second, although glycemic control has been recommended as a part of comprehensive risk factor management in patients with CAD, there is mounting …
学术搜索中的文章
SV Arnold, DL Bhatt, GW Barsness, AL Beatty… - Circulation, 2020